http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#Head http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#assertion http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#provenance http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#pubinfo http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#assertion http://purl.obolibrary.org/obo/DOID_6132 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_6132 http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB06151 http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#association http://www.w3.org/2000/01/rdf-schema#label acetylcysteine solution usp is indicated as adjuvant therapy for patients with abnormal viscid or inspissated mucous secretions in such conditions as chronic bronchopulmonary disease chronic emphysema emphysema with bronchitis chronic asthmatic bronchitis tuberculosis bronchiectasis and primary amyloidosis of the lung acute bronchopulmonary disease pneumonia bronchitis tracheobronchitis pulmonary complications of cystic fibrosis tracheostomy care pulmonary complications associated with surgery use during anesthesia post traumatic chest conditions atelectasis due to mucous obstruction diagnostic bronchial studies bronchograms bronchospirometry and bronchial wedge catheterization acetylcysteine solution usp administered orally is indicated as an antidote to prevent or lessen hepatic injury which may occur following the ingestion of a potentially hepatotoxic quantity of acetaminophen it is essential to initiate treatment as soon as possible after the overdose and in any case within 24 hours of ingestion http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB06151 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#provenance http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#pubinfo http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#sig http://purl.org/nanopub/x/hasSignature CAoxUlMxZ3BipSOpPcVZgPRvFf8lvtbEGKlV8Uzni7rwccx89BIWwCjg4Gfa4rDWFgpRrLwMJwdXiFid0bUrlkUx5gfgmTUgbYy1TQgK6Uzlgs2IzssOtkaaRWZtVTiBd4ntWJ5mlkE5GdfHCgS0kupjqp0EsEHSfLCzIMn/Epk= http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc http://purl.org/dc/terms/created 2021-06-14T08:15:17.036+02:00 http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAiydx08XNJGY6p9M6rEp7q95MYz76kazeFjIbbTWTJvc https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs